Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06664320
NA

Mild ANH on Pre-bypass Coagulation Function During Cardiac Surgery

Sponsor: Konkuk University Medical Center

View on ClinicalTrials.gov

Summary

The impact of acute normovolemic hemodilution (ANH) using hydroxyethyl starch before initiating cardiopulmonary bypass (CPB) on whole blood viscoelastic profile after CPB has not been well established. Patients undergoing cardiac surgery employing moderate hypothermic CPB are randomly allocated into one of two groups: in Group-ANH, ANH is applied by using a balanced hydroxyethyl starch (HES 130/0.6); and in Group-C, ANH is not applied. After weaning from CPB, intergroup differences of INTEM, EXTEM, FIBTEM, and APTEM profiles are analyzed. As a primary outcome, the inter-group differences between maximal clot firmness of EXTEM will be determined at 10 min after ANH in Group-ANH and that at control.

Official title: Impact of Mild Acute Normovolemic Hemodilution on Pre-bypass Coagulation Function During Cardiac Surgery

Key Details

Gender

All

Age Range

19 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

70

Start Date

2024-10-28

Completion Date

2025-04-30

Last Updated

2024-10-31

Healthy Volunteers

No

Interventions

PROCEDURE

Acute normovolemic hemodilution (ANH)

applying acute normovolemic hemodilution (ANH) by using HES 130/0.4 of 5 ml/kg before the initiation of cardiopulmonary bypass

DRUG

hydroxyethyl starch (HES 130/0.6)

hydroxyethyl starch (HES 130/0.6)

Locations (2)

Konkuk University Medical Center

Seoul, Seoul, South Korea

Konkuk University Medical Center

Seoul, South Korea